Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from CSL Behring.

Clinical Consultations: An Expert Discussion on Immunoglobulin Therapy in CIDP — Optimizing Treatment to Improve Quality of Life

Release Date: September 3, 2020
Expiration Date: September 3, 2021

Activity Overview

This Clinical Consultations educational activity is a video-based program in which 2 experts talk about the diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Topics include the impact of CIDP on patient’s lives, available treatment options including immunoglobulins, and the treatment goals of therapy.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from CSL Behring.

Target Audience

This online educational activity is directed towards neuromuscular focused neurologists. Additional health care clinicians involved in the management of patients with CIDP will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Review the pathophysiology and symptomatology of CIDP and its variants
  • Discuss management considerations for the use of IVIG and SCIG in practice
  • Evaluate efficacy and safety data for immunoglobulins in the treatment of patients with CIDP

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Lynette M. Sholl, MD
Chafic Karam, MD
Associate Professor of Neurology
Chief, Neuromuscular Division
Oregon Health & Science University
Portland, OR


Disclosures: Grant/Research Support: Sanofi Genzyme, Akcea Therapeutics Inc; Consultant: Acceleron Pharma Inc, Akeca Therapeutics Inc, Alexion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Argenx SE, Biogen Inc, CSL Behring, Cytokinetics Inc, Sanofi Genzyme

Lynette M. Sholl, MD
Tuan Vu, MD
Professor of Neurology
Director, Neuromuscular Division, EMG Laboratories, and ALS Clinic
Department of Neurology
University of South Florida
Tampa, FL

Disclosures: Grant/Research Support: CSL Behring, Biogen, Alexion Pharmaceuticals Inc, Argenyx SE, UCB/RA, MTPA; Consultant: Alexion Pharmaceuticals Inc, Argenx SE, UCB/RA; Speaker’s Bureau: Alexion Pharmaceuticals Inc, CSL Behring, Allergan 

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By